Compare Abbott Laboratories (ABT) vs Ishares Msci Italy ETF (EWI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Ishares Msci Italy ETF — how do they compare? Abbott Laboratories trades at $95.13 (market cap $166.94B), while Ishares Msci Italy ETF trades at $60.07. The key difference: Abbott Laboratories pays a 2.63% dividend while Ishares Msci Italy ETF pays none, and Ishares Msci Italy ETF is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | EWI | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $136.62 | $61.14 |
52-Week Low | $82.57 | $47.32 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
EWI trades at $61.14, up 0.84% today, with a bullish technical signal driven by moving averages. The stock recently hit a 52-week high (Zacks Investment Research, 2026-06-10), supported by improving Italian industrial data. A dividend of $1.17 is scheduled for payment on June 18, 2026. However, key valuation ratios like P/E and P/S are unavailable, limiting fundamental clarity.
Outlook is mixed: technical strength and European equity inflows (Proactive Investors, 2026-07-07) offer upside, but stagflation risks in Italy (Seeking Alpha, 2026-06-04) and ECB rate hikes (Bloomberg, 2026-06-11) pose headwinds. Investors should weigh bullish momentum against macroeconomic uncertainties and incomplete financial data.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Ishares Msci Italy ETF
EWI is a country-specific ETF that tracks the performance of the Italian equity market. It provides targeted access to large and mid-sized companies in Italy, with a heavy focus on the financial sector and holdings like UniCredit and Intesa Sanpaolo.
Read more on EWI →
